An individualized innovative disease management is of great importance for people with
multiple sclerosis (pwMS) to cope with the complexity of this chronic, multidimensional …

For incurable diseases, such as multiple sclerosis (MS), the prevention of progression and
the preservation of quality of life play a crucial role over the entire therapy period. In MS …

Patient-reported outcomes (PROs) are increasingly used in multiple sclerosis (MS) research
and clinical practice for understanding the effects that the disease and its treatments have on …

Objective To evaluate individual neurofilament light chain (NfL) variation over the time of
disease course and the potential of NfL measurement to predict treatment response in …

Author links open overlay panel A. Glaser a, A. Stahmann b, T. Meissner c, P. Flachenecker
d, D. Horáková e, P. Zaratin fg, G. Brichetto gh, M. Pugliatti ij, O. Rienhoff c, S. Vukusic klmn …

(1) Background: eHealth interventions play a growing role in sha** the future healthcare
system. The integration of eHealth interventions can enhance the efficiency and quality of …

Background: Multiple Sclerosis is a chronic inflammatory disease of the central nervous
system that requires a complex, differential, and lifelong treatment strategy, which involves …

Objective: Fingolimod is approved for the treatment of highly active relapsing remitting
multiple sclerosis (MS) patients and acts by its unique mechanism of action via sphingosine …

Objective To evaluate the 5-year real-world benefit–risk profile of fingolimod in patients with
relapsing–remitting MS (RRMS) in Germany. Methods Post-Authorization Non-interventional …

Multiple sclerosis (MS) is a frequent chronic inflammatory disease of the central nervous
system that affects patients over decades. As the monitoring and treatment of MS become …